Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ VASP Monoclonal Antibody (G.903.3)
Rabbit Monoclonal Antibody
Supplier: Invitrogen™ MA514982
Description
It is not recommended to aliquot this antibody.
Vasodilator-stimulated phosphoprotein (VASP) is a member of the Ena-VASP protein family. Ena-VASP family members contain an EHV1 N-terminal domain that binds proteins containing E/DFPPPPXD/E motifs and targets Ena-VASP proteins to focal adhesions. In the mid-region of the protein, family members have a proline-rich domain that binds SH3 and WW domain-containing proteins. Their C-terminal EVH2 domain mediates tetramerization and binds both G and F actin. VASP is associated with filamentous actin formation and likely plays a widespread role in cell adhesion and motility. VASP may also be involved in the intracellular signaling pathways that regulate integrin-extracellular matrix interactions. VASP is regulated by the cyclic nucleotide-dependent kinases PKA and PKG.
Specifications
VASP | |
Monoclonal | |
62 μg/mL | |
0.01M HEPES with 100 μg/mL BSA, 50% glycerol, 0.15M NaCl and <0.02% sodium azide; pH 7.5 | |
P50552, P70460, Q2TA49 | |
VASP | |
Synthetic peptide corresponding to residues near the carboxy terminus of human and mouse VASP. | |
100 μL | |
Primary | |
Human, Mouse, Rat, Monkey, Bovine, Hamster | |
Antibody | |
IgG |
Immunoprecipitation, Western Blot, Immunocytochemistry | |
G.903.3 | |
Unconjugated | |
VASP | |
Enah/Vasp-like; I79_012660; Unknown (protein for MGC:127789); vasodilator stimulated phosphoprotein; vasodilator-stimulated phosphoprotein; vasodilator-stimulated phosphoprotein (VASP); VASP | |
Rabbit | |
Affinity chromatography | |
RUO | |
100756352, 22323, 361517, 514902, 7408 | |
-20°C | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction